nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Octreotide—thymus cancer	0.854	1	CbGbCtD
Aminosalicylic Acid—Malabsorption—Octreotide—thymus cancer	0.0248	0.3	CcSEcCtD
Aminosalicylic Acid—Abdominal bloating—Octreotide—thymus cancer	0.00757	0.0915	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Octreotide—thymus cancer	0.00562	0.0679	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Octreotide—thymus cancer	0.00539	0.0652	CcSEcCtD
Aminosalicylic Acid—CHUK—hematopoietic system—thymus cancer	0.00387	0.0905	CbGeAlD
Aminosalicylic Acid—CHUK—epithelium—thymus cancer	0.00354	0.0827	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—thymus cancer	0.00273	0.0637	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Octreotide—thymus cancer	0.00268	0.0324	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00262	0.0316	CcSEcCtD
Aminosalicylic Acid—CHUK—thyroid gland—thymus cancer	0.00248	0.0578	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Octreotide—thymus cancer	0.00228	0.0275	CcSEcCtD
Aminosalicylic Acid—CHUK—lung—thymus cancer	0.00225	0.0525	CbGeAlD
Aminosalicylic Acid—ALOX5—hematopoietic system—thymus cancer	0.00218	0.051	CbGeAlD
Aminosalicylic Acid—Weight decreased—Octreotide—thymus cancer	0.00205	0.0247	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Octreotide—thymus cancer	0.00198	0.0239	CcSEcCtD
Aminosalicylic Acid—Jaundice—Octreotide—thymus cancer	0.00197	0.0238	CcSEcCtD
Aminosalicylic Acid—MPO—hematopoietic system—thymus cancer	0.00185	0.0431	CbGeAlD
Aminosalicylic Acid—Hepatitis—Octreotide—thymus cancer	0.00181	0.0219	CcSEcCtD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.00169	0.0815	CbGpPWpGaD
Aminosalicylic Acid—MPO—epithelium—thymus cancer	0.00169	0.0394	CbGeAlD
Aminosalicylic Acid—Malnutrition—Octreotide—thymus cancer	0.00158	0.019	CcSEcCtD
Aminosalicylic Acid—Flatulence—Octreotide—thymus cancer	0.00155	0.0188	CcSEcCtD
Aminosalicylic Acid—CHUK—lymph node—thymus cancer	0.00154	0.0359	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—thymus cancer	0.00154	0.0359	CbGeAlD
Aminosalicylic Acid—Anaemia—Octreotide—thymus cancer	0.00146	0.0176	CcSEcCtD
Aminosalicylic Acid—ALOX5—bone marrow—thymus cancer	0.0014	0.0327	CbGeAlD
Aminosalicylic Acid—ALOX5—thyroid gland—thymus cancer	0.0014	0.0326	CbGeAlD
Aminosalicylic Acid—MPO—pituitary gland—thymus cancer	0.00137	0.032	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00133	0.0161	CcSEcCtD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00133	0.0641	CbGpPWpGaD
Aminosalicylic Acid—MPO—lymphoid tissue—thymus cancer	0.0013	0.0304	CbGeAlD
Aminosalicylic Acid—ALOX5—lung—thymus cancer	0.00127	0.0296	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Octreotide—thymus cancer	0.00126	0.0152	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Octreotide—thymus cancer	0.00126	0.0152	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Octreotide—thymus cancer	0.00125	0.0151	CcSEcCtD
Aminosalicylic Acid—Anorexia—Octreotide—thymus cancer	0.00123	0.0148	CcSEcCtD
Aminosalicylic Acid—MPO—bone marrow—thymus cancer	0.00118	0.0276	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Octreotide—thymus cancer	0.00112	0.0135	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Octreotide—thymus cancer	0.00111	0.0134	CcSEcCtD
Aminosalicylic Acid—MPO—lung—thymus cancer	0.00107	0.025	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Octreotide—thymus cancer	0.00105	0.0127	CcSEcCtD
Aminosalicylic Acid—Urticaria—Octreotide—thymus cancer	0.00102	0.0123	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Octreotide—thymus cancer	0.00102	0.0123	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Octreotide—thymus cancer	0.00102	0.0123	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —CYLD—thymus cancer	0.00097	0.0468	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Octreotide—thymus cancer	0.000948	0.0115	CcSEcCtD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.000907	0.0438	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Octreotide—thymus cancer	0.00088	0.0106	CcSEcCtD
Aminosalicylic Acid—PTGS1—hematopoietic system—thymus cancer	0.000876	0.0205	CbGeAlD
Aminosalicylic Acid—ALOX5—lymph node—thymus cancer	0.000867	0.0202	CbGeAlD
Aminosalicylic Acid—Dizziness—Octreotide—thymus cancer	0.000851	0.0103	CcSEcCtD
Aminosalicylic Acid—PTGS2—hematopoietic system—thymus cancer	0.000837	0.0196	CbGeAlD
Aminosalicylic Acid—Vomiting—Octreotide—thymus cancer	0.000818	0.00988	CcSEcCtD
Aminosalicylic Acid—Rash—Octreotide—thymus cancer	0.000811	0.0098	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Octreotide—thymus cancer	0.00081	0.00979	CcSEcCtD
Aminosalicylic Acid—Headache—Octreotide—thymus cancer	0.000806	0.00974	CcSEcCtD
Aminosalicylic Acid—PTGS1—epithelium—thymus cancer	0.0008	0.0187	CbGeAlD
Aminosalicylic Acid—PTGS2—epithelium—thymus cancer	0.000765	0.0179	CbGeAlD
Aminosalicylic Acid—Nausea—Octreotide—thymus cancer	0.000764	0.00923	CcSEcCtD
Aminosalicylic Acid—MPO—lymph node—thymus cancer	0.000733	0.0171	CbGeAlD
Aminosalicylic Acid—PTGS1—cardiac atrium—thymus cancer	0.000665	0.0155	CbGeAlD
Aminosalicylic Acid—PTGS1—pituitary gland—thymus cancer	0.00065	0.0152	CbGeAlD
Aminosalicylic Acid—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.000623	0.03	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—pituitary gland—thymus cancer	0.000621	0.0145	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—CD4—thymus cancer	0.00059	0.0285	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymphoid tissue—thymus cancer	0.000589	0.0138	CbGeAlD
Aminosalicylic Acid—PTGS1—thyroid gland—thymus cancer	0.00056	0.0131	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL2—thymus cancer	0.000543	0.0262	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—bone marrow—thymus cancer	0.000537	0.0125	CbGeAlD
Aminosalicylic Acid—PTGS1—lung—thymus cancer	0.000509	0.0119	CbGeAlD
Aminosalicylic Acid—PTGS2—lung—thymus cancer	0.000486	0.0114	CbGeAlD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.000423	0.0204	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—KIT—thymus cancer	0.000401	0.0193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.0004	0.0193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AKT phosphorylates targets in the cytosol—AKT1—thymus cancer	0.000373	0.018	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—lymph node—thymus cancer	0.000348	0.00813	CbGeAlD
Aminosalicylic Acid—MPO—Folate Metabolism—IL2—thymus cancer	0.000342	0.0165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymph node—thymus cancer	0.000332	0.00777	CbGeAlD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000325	0.0157	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—CD4—thymus cancer	0.000306	0.0148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—CD4—thymus cancer	0.000298	0.0144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD8A—thymus cancer	0.000277	0.0134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Validated transcriptional targets of TAp63 isoforms—CDKN2A—thymus cancer	0.000254	0.0123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Estrogen signaling pathway—AKT1—thymus cancer	0.000236	0.0114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—CD4—thymus cancer	0.000223	0.0108	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—TP53—thymus cancer	0.00022	0.0106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.000216	0.0104	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.000214	0.0103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—CD4—thymus cancer	0.000204	0.00983	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—KIT—thymus cancer	0.000194	0.00937	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—KIT—thymus cancer	0.00019	0.00914	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—KIT—thymus cancer	0.000188	0.00907	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.000184	0.00887	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—CDKN2A—thymus cancer	0.000178	0.0086	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—AKT1—thymus cancer	0.000169	0.00815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.000169	0.00815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD4—thymus cancer	0.000159	0.00767	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000146	0.00704	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KIT—thymus cancer	0.000145	0.007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000141	0.00678	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KIT—thymus cancer	0.000139	0.0067	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000139	0.00669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KIT—thymus cancer	0.000137	0.00659	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KIT—thymus cancer	0.000131	0.0063	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KIT—thymus cancer	0.00013	0.00628	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KIT—thymus cancer	0.00013	0.00627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KIT—thymus cancer	0.000129	0.00624	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FoxO family signaling—AKT1—thymus cancer	0.000129	0.00622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KIT—thymus cancer	0.000129	0.00621	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CYLD—thymus cancer	0.000128	0.00619	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000127	0.00612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL2—thymus cancer	0.000126	0.0061	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—AKT1—thymus cancer	0.000121	0.00585	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000121	0.00584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KIT—thymus cancer	0.000121	0.00584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KIT—thymus cancer	0.000121	0.00584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KIT—thymus cancer	0.00012	0.00579	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000119	0.00576	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000119	0.00574	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000119	0.00573	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thymus cancer	0.000118	0.00571	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KIT—thymus cancer	0.000118	0.00571	CbGpPWpGaD
Aminosalicylic Acid—CHUK—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000118	0.00567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000118	0.00567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IL-1 signaling pathway—AKT1—thymus cancer	0.000118	0.00567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000116	0.00561	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KIT—thymus cancer	0.000112	0.0054	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000108	0.00522	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000107	0.00517	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000106	0.0051	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.000102	0.0049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—AKT1—thymus cancer	0.000102	0.0049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.0001	0.00485	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—AKT1—thymus cancer	0.0001	0.00485	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—thymus cancer	9.95e-05	0.0048	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—thymus cancer	9.93e-05	0.00479	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—AKT1—thymus cancer	9.81e-05	0.00473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—AKT1—thymus cancer	9.18e-05	0.00443	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	8.38e-05	0.00404	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—AKT1—thymus cancer	8.38e-05	0.00404	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KIT—thymus cancer	8.24e-05	0.00398	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	8.23e-05	0.00397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—AKT1—thymus cancer	7.93e-05	0.00383	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—AKT1—thymus cancer	7.8e-05	0.00376	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	7.47e-05	0.0036	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CYLD—thymus cancer	7.47e-05	0.0036	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—AKT1—thymus cancer	7.41e-05	0.00357	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—AKT1—thymus cancer	7.23e-05	0.00349	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	7.18e-05	0.00346	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—AKT1—thymus cancer	7.18e-05	0.00346	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	7.01e-05	0.00338	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—thymus cancer	6.98e-05	0.00337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—thymus cancer	6.21e-05	0.003	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—thymus cancer	6.01e-05	0.0029	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—thymus cancer	5.9e-05	0.00285	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	5.6e-05	0.0027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—thymus cancer	5.54e-05	0.00267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAML2—thymus cancer	5.48e-05	0.00264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—thymus cancer	5.45e-05	0.00263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—thymus cancer	5.3e-05	0.00256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—thymus cancer	5.24e-05	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—thymus cancer	5.22e-05	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	5.15e-05	0.00248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—thymus cancer	4.98e-05	0.0024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—thymus cancer	4.96e-05	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—thymus cancer	4.93e-05	0.00238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—thymus cancer	4.91e-05	0.00237	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	4.84e-05	0.00233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KIT—thymus cancer	4.7e-05	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	4.62e-05	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—thymus cancer	4.62e-05	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—thymus cancer	4.62e-05	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—thymus cancer	4.58e-05	0.00221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—thymus cancer	4.54e-05	0.00219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—thymus cancer	4.52e-05	0.00218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIT—thymus cancer	4.52e-05	0.00218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—thymus cancer	4.48e-05	0.00216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	4.35e-05	0.0021	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—thymus cancer	4.27e-05	0.00206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	4.09e-05	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAML2—thymus cancer	3.84e-05	0.00185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—thymus cancer	3.65e-05	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—thymus cancer	3.6e-05	0.00173	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—thymus cancer	3.55e-05	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—thymus cancer	3.45e-05	0.00167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAML2—thymus cancer	3.24e-05	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—thymus cancer	3.15e-05	0.00152	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	3.05e-05	0.00147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIT—thymus cancer	2.74e-05	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	2.57e-05	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—thymus cancer	2.53e-05	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—thymus cancer	2.09e-05	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—thymus cancer	1.93e-05	0.000933	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—thymus cancer	1.93e-05	0.00093	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—thymus cancer	1.79e-05	0.000866	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—thymus cancer	1.77e-05	0.000854	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—thymus cancer	1.72e-05	0.000831	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—thymus cancer	1.5e-05	0.000723	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—thymus cancer	1.39e-05	0.000671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—thymus cancer	1.25e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—thymus cancer	1.15e-05	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—thymus cancer	1.05e-05	0.000504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—thymus cancer	9.65e-06	0.000465	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—thymus cancer	8e-06	0.000386	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—thymus cancer	6.76e-06	0.000326	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—thymus cancer	6.03e-06	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—thymus cancer	5.72e-06	0.000276	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—thymus cancer	4.79e-06	0.000231	CbGpPWpGaD
